Delivery Order SPE2DB20D9135-SPE2DB22FD3AF

Award Date 5/20/22
Potential Completion Date 6/13/22
Potential Value $50K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $57,317.20 award is for the supply of MACI 3CM X 5CM IMPLANT SHEETS, a medical device product, with an ultimate completion date of October 1, 2024. This delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA...
This is a firm fixed-price delivery order contract awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, by the Defense Logistics Agency (DLA). The contract, valued at $53,422.99, is for the delivery of MACI 3CM X 5CM IMPLANT SHEETS, a medical device product, to support the recurring pharmaceutical supply needs of military health facilities. The contract is part of DMS Pharmaceutical Group's larger indefinite delivery contract (IDC) with DLA under...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $61,902.91 contract is for the supply of MACI 3CM X 5CM IMPLANT SHEETS, a specialized medical product, with a period of performance through March 3, 2025. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to issue...
This is a $61,902.91 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business. The contract is for the supply of MACI 3CM X 5CM IMPLANT SHEETS, a specialized medical device, to support the recurring medical supply needs of military healthcare facilities. The award is not associated with a set-aside designation, allowing DMS Pharmaceutical Group to leverage its woman-owned small business status to secure this...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $49,597.83 contract is for the provision of MACI 3CM X 5CM implant sheets, a medical device. The delivery order was issued under DMS Pharmaceutical Group's existing indefinite delivery contract (IDC) with the DLA valued at up to $499,999,999, which allows the agency to place orders for a...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $61,902.91 contract is for the supply of MACI 3CM X 5CM IMPLANT SHEETS, a medical device, to support the recurring medical supply needs of military healthcare facilities. DMS Pharmaceutical Group holds a single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB...
This is a firm fixed-price delivery order awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, by the Defense Logistics Agency (DLA). The $57,317.20 contract is for the supply of MACI 3CM X 5CM implant sheets, with a performance period ending on August 5, 2024. The contract is part of a larger indefinite delivery contract (IDC) awarded by the DLA under the SPE2DB program, valued at up to $499,999,999 and running through December 31, 2025. This...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $57,317.20 contract is for the delivery of MACI 3CM X 5CM IMPLANT SHEETS, a specialized pharmaceutical product, with a completion date of November 15, 2024. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program,...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler located in Park Ridge, Illinois. The $53,318.24 award is for the supply of MACI 3CM X 5CM IMPLANT SHEETS to fulfill the recurring pharmaceutical and medical supply needs of the U.S. Department of Defense (DoD) healthcare facilities. DMS Pharmaceutical Group holds a $499,999,999 indefinite delivery contract (IDC) with...
This is a firm fixed-price delivery order contract awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, by the Defense Logistics Agency (DLA) under the SPE2DB program. The $53,318.24 contract is for the delivery of 4561375527 - MACI 3CM X 5CM IMPLANT SHEETS, with a completion date of June 21, 2023. DMS Pharmaceutical Group holds a $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the agency to issue...
  • SPE2DB20D9135
    Indefinite Delivery Contract
  • SPE2DB20D9135-SPE2DB22FD3AF
    Delivery Order

This is a firm fixed-price delivery order awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, by the Defense Logistics Agency (DLA). The $49,714.55 contract is for the supply of MACI 3CM X 5CM IMPLANT SHEETS, a medical device product.

The award is part of DMS Pharmaceutical Group's larger indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999 and running through December 31, 2025. This IDC allows the DLA to issue delivery orders for a comprehensive range of pharmaceutical items to support the diverse medical supply needs of military healthcare facilities worldwide.

DMS Pharmaceutical Group is a key supplier in the federal pharmaceutical supply chain, providing a wide array of branded and generic medications, biologics, and medical consumables to the Department of Defense (DoD) and Department of Veterans Affairs (VA). This specific award does not have a set-aside designation.

Generated 1/9/25, 9:31 AM